Skip to main content

Early Detection Research Network (EDRN)

Visit the EDRN Website

The Early Detection Research Network (EDRN) is a collaborative program that maintains comprehensive infrastructure and resources critical to the discovery, development and validation of biomarkers for cancer risk and early detection.

The DCP Cancer Biomarkers Research Group administers this program.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

About EDRN

The program comprises a public/private sector consortium to accelerate the development of biomarkers that can improve medical practice, ensure data reproducibility and integrity, and adapt to the changing landscape of biomarker science.

Visit the EDRN Website

Grantee Details

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Alexandrov, Ludmil B	University Of California, San Diego United States	Mapping immuno-genomic drivers of the head and neck precancer invasive-disease transition	5U01CA290479-03	Wendy Wang, Ph.D., M.Sc.
Allen, Peter J	Duke University United States	Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas	5R01CA182076-08	Matthew Young, Ph.D.
Amuta, Ann Oyare	University Of Texas Arlington United States	Development of Tailored, Multilevel Cervical Cancer Interventions for Ethnically Diverse Black Women	1R15CA294297-01	Goli Samimi, Ph.D., M.P.H.
Anderson, Garnet L.	Fred Hutchinson Cancer Center United States	NCI Cancer Screening Research Network: Coordinating and Communication Center	3UG1CA286954-02S1	Elyse LeeVan, M.D., M.P.H.
Anderson, Daniel M	Healthpartners Institute United States	Metro-Minnesota Community Oncology Research Consortium (MMCORC)	3UG1CA189863-12S1	Vanessa A. White, M.P.H.
Anderson, Daniel M	Healthpartners Institute United States	Metro-Minnesota Community Oncology Research Consortium (MMCORC)	3UG1CA189863-12S1	Vanessa A. White, M.P.H.
Anderson, Karen Sue	Arizona State University-Tempe Campus United States	Southwest EDRN Clinical Validation Center for Head and Neck Cancer	5U01CA281660-03	Wendy Wang, Ph.D., M.Sc.
Anderson, Karen Sue	Arizona State University-Tempe Campus United States	Southwest EDRN Clinical Validation Center for Head and Neck Cancer	5U01CA281660-03	Wendy Wang, Ph.D., M.Sc.
Arnold, Corey Wells	University Of California Los Angeles United States	Computational Feature Profiling and Modeling for Prostate Cancer Detection and Risk Stratification	5R01CA279666-02	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Atigadda, Venkatram Reddy	University Of Alabama At Birmingham United States	Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer	5R01CA276683-03
Backman, Vadim	Northwestern University At Chicago United States	Optical hyperspectral nanoscale chromatin analysis for colon cancer risk-stratification	1R01CA289294-01A1	Claire Zhu, Ph.D.
Badu-Tawiah, Abraham	Ohio State University United States	Multiplexed Paper-Based Blood Test for Early-Stage Colorectal Cancer Screening	5R21CA270727-02	Claire Zhu, Ph.D.
Badve, Sunil S.	Emory University United States	Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms	5R01CA281932-02	Wendy Wang, Ph.D., M.Sc.
Bae-Jump, Victoria Lin	Univ Of North Carolina Chapel Hill United States	Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer	5R37CA226969-07	Goli Samimi, Ph.D., M.P.H.
Baghdadi, Tareq Al	Saint Joseph Mercy Health System United States	Michigan Cancer Research Consortium NCORP	3UG1CA189971-11S1	Vanessa A. White, M.P.H.

News and Events